Medtronic Plc. (MDT) closed at $101.59 on November 10, 2026, down 1.2% from the previous close, on volume of 4,670,739 shares (30-day average 25,127,678).
Data as of November 10, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 14, 2026 | Ratio Put Spread 1 by 1.35 | 18-Dec-2682.5[1.35x] : 90 P | 23,500 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 10, 2026. See the 10 largest for 30, 60 and 90 days
Orchestra BioMed Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates
Globe Newswire (Tue, 10-Nov 4:10 PM ET)
Imperative Care Announces Two New Board of Directors Appointments
Business Wire (Tue, 10-Nov 8:00 AM ET)
Orchestra BioMed Announces Pricing of Public Offering
Globe Newswire (Thu, 5-Nov 10:42 PM ET)
Orchestra BioMed Announces Proposed Public Offering
Globe Newswire (Thu, 5-Nov 4:01 PM ET)
Medtronic to announce financial results for its second quarter of fiscal year 2027
PRNewswire (Wed, 4-Nov 4:15 PM ET)
/C O R R E C T I O N - The Michael J. Fox Foundation for Parkinson's Research/
PRNewswire (Wed, 4-Nov 10:02 AM ET)
Market Chameleon (Wed, 4-Nov 3:31 AM ET)
PRNewswire (Wed, 4-Nov 8:00 AM ET)
PRNewswire (Wed, 4-Nov 8:00 AM ET)
Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026
Globe Newswire (Thu, 29-Oct 8:30 AM ET)
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, surgical robots, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
Medtronic Plc. trades on the NYSE stock market under the symbol MDT.
As of November 11, 2026, MDT stock price declined to $100.64 with 309,977 million shares trading.
MDT has a beta of -0.37, meaning it tends to be less sensitive to market movements. MDT has a correlation of 0.03 to the broad based SPY ETF.
MDT has a market cap of $128.82 billion. This is considered a Large Cap stock.
Last quarter Medtronic Plc. reported $10 billion in Revenue and $1.45 earnings per share. This beat revenue expectation by $226 million and exceeded earnings estimates by $.06.
In the last 3 years, MDT traded as high as $106.33 and as low as $71.64.
The top ETF exchange traded funds that MDT belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
MDT has underperformed the market in the last year with a return of +11.7%, while SPY returned +12.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MDT shares. However, MDT has outperformed the market in the last 3 month and 2 week periods, returning +13.4% and +7.1%, while SPY returned -2.0% and -1.8%, respectively. This indicates MDT has been having a stronger performance recently.
MDT support price is $99.75 and resistance is $103.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDT shares will trade within this expected range on the day.
